Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

ESMO-MCBS: A practical tool with public health implications

Progression-free survival: Should it be used as a primary end point for registration of anticancer treatments and what is the role of the ESMO-MCBS?

Date

13 Sep 2024

Session

ESMO-MCBS: A practical tool with public health implications

Topics

Clinical Research;  Response Evaluation (RECIST Criteria);  Statistics

Tumour Site

Presenters

Bishal Gyawali

Authors

B. Gyawali

Author affiliations

  • Medical Oncology Department, KAHS - Karnali Academy of Health Sciences, 21200 - Chandannath/NP

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Sjoukje Oosting

Session: ESMO-MCBS: A practical tool with public health implications

Resources:

Slides

Webcast

Conclusions and perspectives

Presenter: Nathan Cherny

Session: ESMO-MCBS: A practical tool with public health implications

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.